Loading…
SHC
Sotera Health Co
NASDAQ· Healthcare· Diagnostics & Research· CUSIP 83601L102
$18.13+2.03%Price as of Oct 23, 00:48 UTC · updated once a day, after the close
At a glance
Sotera Health Co (SHC) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Broadview Heights, United States and has 3,000 employees. The company is worth $5.17B and trades at 31.3x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was $1.16B in fiscal 2025, up 5.7% from the year before. Net income was $77.95M. The share price is 8.7% below its 52-week high of $19.85. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $186.4M. In that quarter, 3 of them opened or added to the position and 1 reduced it. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $5.17B
- P/E
- 31.3x
- Forward P/E
- 16.9x
- P/B
- 7.8x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- $0.58
- ROE
- 27.78%
- Profit margin
- 13.44%
- Revenue growth
- +9.20%
- Beta
- 1.85
- 52-week high
- $19.85
- 52-week low
- $13.09
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -16.2% over 5Y.
today you would have $724.29▼ -27.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 6 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $17.64 | $13.68 | $16.85 | $8.33 | $23.55 | $27.44 | |
| P/E | 75.4x | 65.3x | 85.5x | 93.6x | — | 57.4x | — |
| P/S | 4.4x | 4.3x | 3.5x | 4.5x | 2.3x | 7.2x | 8.0x |
| P/B | 10.2x | 8.3x | 9.6x |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
$5.52
Square root of 22.5 × earnings × book value. Blind to intangibles, so it undervalues software and brands.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
$14.09
Median P/E of 24.3 among peers in the sector.
Earnings
$43.74
Median P/E of 75.4 across this company’s own years on record.
Cash flow
$2.28
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
—
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SRRKScholar Rock Holding Corp | $41.96 | — | 20.1x | 0.00% | -167.77% | $5.11B |
| CONConcentra Group Holdings Parent, Inc. | $39.97 | 25.3x | 10.7x | 0.63% | 47.06% | $5.1B |
| PTCTPtc Therapeutics Inc | $63.04 | — | — | 0.00% | — | $5.26B |
| GRFSGrifols SA | $7.45 |
About the company
- 3,000
- Broadview Heights, United States
